Arimidex

Tamoxifen soothes effects of prostate cancer treatment

The anti-estrogen tamoxifen appears to suppress gynecomastia and breast pain in men undergoing androgen-suppression therapy for prostate cancer.

Drug combination extends survival in metastatic breast cancer

Coadministration of anastrozole (Arimidex) and fulvestrant (Faslodex) improved survival in women with HR-positive metastatic breast cancer.

Concurrent anastrozole/fulvestrant could be new first-line breast cancer treatment

Administering anastrozole (Arimidex) and fulvestrant (Faslodex) in combination rather than in sequence extended overall survival by 6 months in women with metastatic breast cancer, researchers reported at the CTRC-AACR San Antonio Breast Cancer Symposium.

Toxicity indicates success in breast cancer

Vasomotor and joint symptoms in breast cancer patients receiving endocrine treatment may indicate treatment success, according to a retrospective analysis of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs